Mentoring Faculty in the ADRD Training Program

Mentors1

The ADRD Training Program has enlisted the participation of the following faculty as Mentors, due to their expertise in the following fields:

  • Cellular, computational & animal modeling of addiction, aging, hypoxia, AD, FTD, ALS, & PD
  • Neurodegeneration & inflammation
  • Cognition & aging
  • Addiction, psychiatric & behavioral disorders, sleep & hypoxia
  • Neuropathology & neuroimaging
  • Genetics, RNA biology & viral transduction
  • Use of large-scale, open-format databases
  • Clinical diagnostics, clinical neuropsychology & behavioral interventions of AD & overlapping conditions

Jose Abisambra, PhD

Identifying mechanisms of tau-mediated neurodegeneration in tauopathies.

abisambra

Russel Bauer, PhD

Structure-function relationships in memory disorders using structural brain imaging techniques.

Rus Bauer

Jennifer Bizon, PhD

Mechanisms of brain aging and the implications for cognitive function.

Jennifer Bizon

David Borchelt, PhD

Modeling neurodegeneration and protein misfolding in ADRD.

David Borchelt

Dawn Bowers, PhD

Neuropsychology of cognition and emotion.

Dawn Bowers

Sara Burke, PhD

Uncovering mechanisms of age-related impairments in ADRD.

Sara Burke

Paramita Chakrabarty, PhD

Understanding the role of immune activation in neurodegeneration.

Chakrabarty

Ronald Cohen, PhD

Discovering ways of delaying or ameliorating normal cognitive aging — cognitive decline not caused by disease.

Ronald Cohen

Thomas Foster, PhD

Identifying mechanisms for age-related memory impairment and to test treatments to alleviate memory deficits.

Foster-Tom

Benoit Giasson, PhD

Understanding the regulation of protein interactions and folding that affect protein aggregation in the nervous system.

Benoit Giasson

Todd Golde, MD PhD

Conducting disease-oriented research with a specific, but not exclusive, focus on neurodegenerative diseases.

Golde 2

Michael Jaffee, MD

Utilizing a multidisciplinary approach to developmental strategies for assessment and management of traumatic brain injury.

Dr. Michael Jaffee

Habibeh Khoshbouei, PharmD, PhD

Identifying novel mechanisms involved in regulation of dopamine neurotransmission in the brain.

Habibeh Khoshbouei

Matthew Farrer, PhD

Genetic and functional analysis of neurologic and neurodegenerative disorders.

Dr. Matthew Farrer

Marcelo Febo, PhD

Our laboratory uses magnetic resonance imaging to measure in vivo functional and microstructure changes in mouse models of Alzheimer’s disease and related dementias.

Dr. Marcelo Febo

Jada Lewis, PhD

Creating, characterizing, and utilizing genetically manipulated in vivo models of neurodegenerative diseases.

Jada Lewis

Carol Mathews, MD

Identifying the causes and neural underpinnings of obsessive compulsive and anxiety spectrum disorders.

Dr. Carol Mathews

Andrew Maurer, PhD

Understanding how the brain rapidly translates environmental information into complex representations in support of cognitive function.

maurer

Gordon Mitchell, PhD

Identifying fundamental mechanisms of spinal respiratory motor plasticity induced by intermittent hypoxia, and attempts to harness that plasticity to treat devastating clinical disorders that compromise breathing and non-respiratory limb movements, such as cervical spinal injury and ALS.

Gordon Mitchell

Sara Jo Nixon, PhD

Examining the acute and chronic effects of alcohol and other drugs.

SJN1

Michael Okun, MD

Exploring the cognitive, behavioral, and mood effects of deep brain stimulation (DBS)

okun

Catherine Price, PhD

Examining the predictive value of patients’ white and gray matter structure integrity on disease associated cognitive decline and vulnerability to cognitive change after elective medical interventions with anesthesia.

price_catherine

Laura Ranum, PhD

Utilizing models to understand how genetic mutations cause neurodegenerative diseases.

Dr. Laura Ranum

Diego Rincon-Limas, PhD

Development and application of new technologies to define the molecular pathways leading to neurodegeneration and identification of potential therapeutic targets

diego-rincon-limas

Barry Setlow, PhD

Investigating how acute and chronic exposure to drugs of abuse affects cognitive and motivational outcomes.

Barry Setlow

Glenn Smith, PhD

Early detection of neurodegenerative diseases and the methods to prevent or delay the development of dementia.

Glenn Smith

Maurice Swanson, PhD

How RNA processing is regulated during embryonic, fetal and postnatal development and how this regulation is disrupted in neurological disease, particularly in microsatellite expansion disorders.

Swanson

Malú Tansey, Ph.D.

Investigating the role and regulation of neuroinflammatory and immune system responses in modulating the gene-environment interactions that determine risk for development and progression of neurodegenerative and neuropsychiatric disease.

Malu Tansey

Eric Wang, PhD

His lab is focused on three main areas – 1) studying the pathogenesis of microsatellite repeat diseases, in particular myotonic dystrophy, 2) studying the basics of how RNA is processed and localized in cells in tissues, and 3) combining insights made in both of those areas to develop treatments for people with these diseases.

eric_wang

Daniel Wesson, PhD

Testing specific hypotheses regarding the neural basis of sensory dysfunction in neurological disorders, including dementias and addiction, wherein sensory processing is aberrant.

Daniel Wesson

Adam Woods, PhD

Identify and implement methods of non-invasive neuromodulation interventions to make a meaningful impact on age-related conditions and disorders.

Adam Woods

ALZHEIMER'S T32 Mentoring Faculty

Need to submit or update your bio?

aerial view